11. May 2017

Established in 2008 and now celebrating our 10th consecutive year, the scope of BOS cmc 2017 will cover development stage CMC outsourcing for both small molecules and biologics (including novel therapeutic entities such as cell therapies and gene therapies). Our programme is divided into small molecule and biologics tracks and includes the following modules: Outsourcing Business Process: Building Effective Outsourcing Partnerships: Early Development Outsourcing: Late Stage Outsourcing: Drug Deli